Company:  MOMENTA PHARMACEUTICALS I ... (MNTA)
Form Type:  S-8
Filing Date:  8/10/2018 
CIK:  0001235010 
Address:  301 BINNEY STREET 
City, State, Zip:  CAMBRIDGE, Massachusetts 02142 
Telephone:  617 491-9700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$26.85  
Change: 
1.25 (4.88%)  
Trade Time: 
04:15 PM EST  
Market Cap: 
$2.10B
Trade MNTA now with

© 2018  
Description of Business
We are a biotechnology company focused on developing generic versions of complex drugs, biosimilars and novel therapeutics for autoimmune disease. Our approach to drug discovery and development is built around a complex systems analysis platform that we use to obtain a detailed understanding of complex chemical and biologic systems, design product candidates, evaluate the biological function of products and product candidates, and develop reliable and scalable manufacturing processes. The core objective of our platform is to resolve the complexity of molecular structures and related biologic systems. We first map the key measurements needed to obtain comprehensive data on a targeted molecular structure and related biology and then develop a set of analytic tools and methods, including standard, modified and proprietary analytics, to generate the data, including multiple related and complementary, or orthogonal, measures. We also utilize proprietary data analytics software.
Register and access this filing in:     
  FORM S-8
    CALCULATION OF REGISTRATION FEE
    EXPLANATORY NOTE
      Item 8. Exhibits.
    SIGNATURES
    POWER OF ATTORNEY AND SIGNATURES
  EXHIBIT 5.1
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm